v3.26.1
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
$ in Thousands
Jun. 27, 2026
Dec. 27, 2025
Current assets:    
Cash and cash equivalents $ 192,025 $ 213,770
Trade receivables and contract assets, net of allowances for credit losses of $8,715 and $10,463, respectively 711,755 708,856
Inventories 346,260 299,103
Prepaid assets 100,409 96,108
Other current assets 178,657 129,212
Total current assets 1,529,106 1,447,049
Property, plant and equipment, net 1,494,914 1,655,219
Venture capital and strategic equity investments 206,470 206,972
Operating lease right-of-use assets, net 330,247 361,415
Goodwill 3,076,851 2,764,253
Intangible assets, net 253,174 339,995
Deferred tax assets 53,827 67,334
Other assets 587,556 293,185
Total assets 7,532,145 7,135,422
Current liabilities:    
Accounts payable 140,983 148,800
Accrued compensation 187,835 268,854
Deferred revenue 203,035 210,418
Accrued liabilities 380,101 270,085
Other current liabilities 222,792 222,158
Total current liabilities 1,134,746 1,120,315
Long-term debt, net and finance leases 2,619,985 2,136,360
Operating lease right-of-use liabilities 407,708 434,048
Deferred tax liabilities 78,668 95,203
Other long-term liabilities 402,511 138,302
Total liabilities 4,643,618 3,924,228
Commitments and contingencies (Notes 2, 12, 14, and 16)
Redeemable noncontrolling interests 42,537 41,263
Equity:    
Preferred stock, $0.01 par value; 20,000 shares authorized; no shares issued and outstanding 0 0
Common stock, $0.01 par value; 120,000 shares authorized; 49,550 shares issued and 47,728 shares outstanding as of June 27, 2026, and 49,217 shares issued and outstanding as of December 27, 2025 496 492
Additional paid-in capital 1,986,023 1,947,301
Retained earnings 1,372,295 1,388,620
Treasury stock, at cost, 1,822 and zero shares, as of June 27, 2026 and December 27, 2025, respectively (323,189) 0
Accumulated other comprehensive loss (195,989) (171,783)
Total Charles River Laboratories International, Inc. equity 2,839,636 3,164,630
Nonredeemable noncontrolling interest 6,354 5,301
Total equity 2,845,990 3,169,931
Total liabilities, redeemable noncontrolling interests and equity $ 7,532,145 $ 7,135,422